Nesiritide Reference

Educational, not medical advice reference for Nesiritide: Hormonal; regulatory status, evidence posture, source review, and schedule notes. Also…

Plain English

What it is
Nesiritide (brand name Natrecor) is a lab-made copy of a natural heart hormone called B-type natriuretic peptide, or BNP. It is a prescription medicine that the U.S. FDA approved for hospital use, given straight into a vein through an IV.
What people use it for
Doctors use it in the hospital to treat people whose heart failure has suddenly gotten much worse, so much that they feel short of breath even at rest or with light activity. It works for a short time to help relax blood vessels and ease that breathlessness. There is no at-home or personal-use version of this drug.
What the science shows
Testing is in humans, but the results are modest. A large, careful trial found it eased breathing only a little and did not lower the chance of dying or being sent back to the hospital.
The catch
This is a hospital-only medicine that trained clinicians give through an IV, and its main listed risk is a drop in blood pressure (low blood pressure). It is not a fitness, fat-loss, or self-use peptide, and it is not something a person can safely take on their own.

Reference summary

Nesiritide is a label-verified recombinant BNP. pepSmart surfaces label-reference content only.

Regulatory and posture

Categories
Hormonal
Aliases
Natrecor, Recombinant human B-type natriuretic peptide, Recombinant BNP
Evidence posture
human
Regulatory status
FDA-approved prescription medication (Natrecor). Indicated for intravenous treatment of acutely decompensated heart failure in patients with dyspnea at rest or with minimal activity. Hospital clinician-administered only.
Content review status
label verified

Selected public sources

For research and educational purposes only. Not medical advice.